ReviewDrug design, development and therapy2024

New Perspectives on Obesity-Associated Nephropathy from Pathophysiology to Therapeutics: Revealing the Promise of GLP-1 RA Therapy.

Linan Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.